Recent Patent Cases and Generic Delays: 2023-2025 Examples
Generic drugs approved by the FDA often face multi-year delays due to patent lawsuits. Between 2023 and 2025, patent thickets, the 30-month stay, and litigation costs blocked affordable access for millions of patients.
